Metraipolis › archive › dc_c91131df48af

The efficacy of regorafenib combined with PD-1/PD-L1 inhibitor in advanced or metastatic colorectal cancer: A single arm meta-analysis — Europe PMC PMID:41578466

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41578466
DOI
10.1097/md.0000000000047284
License (as archived)
solo-consultazione
Archived
2026-11-07T05:06:46.650Z
SHA-256 of the archived text
20597eccf796903f2d4f79434882c8281339d2229bb6ef6eb2ae9d51f17f07ba
Stable URL of this page
https://metraipolis.com/documento/dc_c91131df48af

How to cite

The efficacy of regorafenib combined with PD-1/PD-L1 inhibitor in advanced or metastatic colorectal cancer: A single arm meta-analysis — Europe PMC PMID:41578466 — Europe PMC (en), https://europepmc.org/article/MED/41578466 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c91131df48af (Metraipolis archive dc_c91131df48af, sha256 20597eccf796903f2d4f79434882c8281339d2229bb6ef6eb2ae9d51f17f07ba)
BibTeX
@misc{dcc91131df48af,
  title = {The efficacy of regorafenib combined with PD-1/PD-L1 inhibitor in advanced or metastatic colorectal cancer: A single arm meta-analysis — Europe PMC PMID:41578466},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41578466},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c91131df48af; sha256 20597eccf796903f2d4f79434882c8281339d2229bb6ef6eb2ae9d51f17f07ba},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41578466. Agents can read the archived copy with the MCP tool read_document.